Clinical Trial Update: A Phase 2 Study of Jaktinib in Participants With Moderate to Severe Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update reports the completion of a Phase 2 study evaluating jaktinib in participants with plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Jaktinib (jaktinib)

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Moderate-to-Severe Plaque Psoriasis | Phase 2 | Status: COMPLETED